InvestorsHub Logo
Followers 55
Posts 2608
Boards Moderated 0
Alias Born 02/04/2014

Re: BioNewton post# 36312

Wednesday, 06/03/2015 11:04:42 AM

Wednesday, June 03, 2015 11:04:42 AM

Post# of 144815
I bet this is the data that got Dr Von Hoff's attention. Now we have a much improved Cell in a Box(R) technology in similar preclinical trials only this time TD2 used an ovarian cancer as opposed to colon cancer. Additionally, Dr Von Hoff has personally assisted in architecting the studies in preparation for human trials.

This is very good news. I had never seen this data before but can only guess that the current trials must be at least as good but more likely, even better with all of the improvents to the technology.

My confidence is even greater knowing that Dr Von Hoff will be leading the march to the FDA and TD2 will be conducting human trials. The video is worth watching again while keeping these historic results in mind...

"Complete Tumor Remission"


http://www.pharmacytebiotech.com/media/

http://finance.yahoo.com/news/pharmacyte-biotechs-cancer-treatment-shows-133000454.html
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent PMCB News